Genetics

This blog post examines how recent advances in multiple sclerosis genetics are reshaping scientific understanding of the disease, moving beyond genetic susceptibility toward the mechanisms that influence disease severity and long-term disability. Drawing on Sahi and colleagues’ review, it explains how immune-related risk variants, especially HLA-DRB1*1501, contribute to disease onset and inflammatory activity, while emerging severity-associated variants such as rs10191329 point toward CNS resilience, neurodegeneration, and repair. The post also discusses why replication of severity findings remains challenging and why deeper phenotyping, diverse genetic cohorts, and gene-environment research are essential for future prognostic tools and targeted treatments.